Literature DB >> 18694731

Galactose-poly(ethylene glycol)-polyethylenimine for improved lung gene transfer.

Jun Chen1, Xiaoling Gao, Kaili Hu, Zhiqing Pang, Jia Cai, Jingwei Li, Hongbing Wu, Xinguo Jiang.   

Abstract

n class="Chemical">Polyethylenimine (pan> class="Chemical">PEI) is a potential gene transfer agent, but is limited by its poor transfection efficiency in vivo due to poor solubility and stability, pronounced toxicity and non-specific interaction with target cells. To improve its pulmonary gene transfection property, galactose (whose binding lectins are abundantly expressed in the lung) was selected as a ligand to improve the binding and uptake of the modified PEI/pDNA (plasmid DNA) polyplexes into lung cells. A novel protocol was developed to synthesize galactose-polyethylenglycol (PEG)-PEI copolymers. The resulting galactose-PEG-PEI/pDNA polyplexes showed improved solubility, stability, and reduced toxicity. Compared with that obtained by PEI/pDNA at a N/P ratio of 6, the transfection efficiency of 1% galactose-PEG-PEI/pDNA polyplexes at the N/P ratio of 36 was 4.5- and 11.6-fold in the A549 cell line and in mice lung, respectively. These data taken suggest that galactose-PEG-PEI may be a promising pulmonary gene delivery system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694731     DOI: 10.1016/j.bbrc.2008.08.006

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Differential uptake of DNA-poly(ethylenimine) polyplexes in cells cultured on collagen and fibronectin surfaces.

Authors:  Anandika Dhaliwal; Maricela Maldonado; Zenas Han; Tatiana Segura
Journal:  Acta Biomater       Date:  2010-04-03       Impact factor: 8.947

Review 2.  Designing polymers with sugar-based advantages for bioactive delivery applications.

Authors:  Yingyue Zhang; Jennifer W Chan; Alysha Moretti; Kathryn E Uhrich
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

3.  Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).

Authors:  Devaraja Rajasekaran; Jyoti Srivastava; Kareem Ebeid; Rachel Gredler; Maaged Akiel; Nidhi Jariwala; Chadia L Robertson; Xue-Ning Shen; Ayesha Siddiq; Paul B Fisher; Aliasger K Salem; Devanand Sarkar
Journal:  Bioconjug Chem       Date:  2015-06-25       Impact factor: 4.774

4.  Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid.

Authors:  Clark J Needham; Austin K Williams; Sue Anne Chew; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomacromolecules       Date:  2012-04-11       Impact factor: 6.988

5.  Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.

Authors:  Janjira Intra; Aliasger K Salem
Journal:  J Drug Target       Date:  2010-08-03       Impact factor: 5.016

6.  Cross-linked polyethylenimine-tripolyphosphate nanoparticles for gene delivery.

Authors:  Xianzhang Huang; Sujing Shen; Zhanfeng Zhang; Junhua Zhuang
Journal:  Int J Nanomedicine       Date:  2014-10-16

7.  Development of Covalent Chitosan-Polyethylenimine Derivatives as Gene Delivery Vehicle: Synthesis, Characterization, and Evaluation.

Authors:  Laura Nicolle; Jens Casper; Melanie Willimann; Céline M A Journot; Pascal Detampel; Tomaž Einfalt; Hiu Man Grisch-Chan; Beat Thöny; Sandrine Gerber-Lemaire; Jörg Huwyler
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

Review 8.  Directing the Way-Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery.

Authors:  Ricarda Carolin Steffens; Ernst Wagner
Journal:  Pharm Res       Date:  2022-09-15       Impact factor: 4.580

Review 9.  Nanomedicine in pulmonary delivery.

Authors:  Heidi M Mansour; Yun-Seok Rhee; Xiao Wu
Journal:  Int J Nanomedicine       Date:  2009-12-29

Review 10.  Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy.

Authors:  Piotr Tarach; Anna Janaszewska
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.